Shares in Valneva plunged 35% on Monday after it said the British government had ended a COVID-19 vaccine supply deal that could have been worth up to 1.4 billion euros ($1.65 billion). The shares made up some of the lost ground on Tuesday, regaining more than 8%, to close at 12.60 euros. Source: Reuters 14/9/2021